These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15581075)

  • 1. Effect of a change in crystal polymorph on the degree of adhesion between micronized drug particles and large homogenous carrier particles during an interactive mixing process.
    Song M; de Villiers MM
    Pharm Dev Technol; 2004 Nov; 9(4):387-98. PubMed ID: 15581075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
    Zeng XM; Pandhal KH; Martin GP
    Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of highly porous direct compression carrier particles with improved drug loading during an interactive mixing process.
    Song M; Li N; Tiedt LR; Degennaro MD; de Villiers MM
    AAPS PharmSciTech; 2010 Jun; 11(2):698-707. PubMed ID: 20414757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal doping aided by rapid expansion of supercritical solutions.
    Vemavarapu C; Mollan MJ; Needham TE
    AAPS PharmSciTech; 2002; 3(4):E29. PubMed ID: 12916923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterisation of interactive mixtures with a fine-particulate mucoadhesive carrier for nasal drug delivery.
    Fransén N; Björk E; Nyström C
    Eur J Pharm Biopharm; 2007 Sep; 67(2):370-6. PubMed ID: 17451925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
    Shalash AO; Elsayed MMA
    AAPS PharmSciTech; 2017 Nov; 18(8):2862-2870. PubMed ID: 28421352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polydisperse powder mixtures: effect of particle size and shape on mixture stability.
    Swaminathan V; Kildsig DO
    Drug Dev Ind Pharm; 2002 Jan; 28(1):41-8. PubMed ID: 11858523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Content uniformity of microdose tablets (dosage 1 microgram--10 mg) produced by fluid bed granulation of interactive mixtures.
    Thiel WJ; Nguyen LT; Sberna FJ
    J Pharm Pharmacol; 1986 May; 38(5):335-43. PubMed ID: 2872308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug agglomeration and dissolution--what is the influence of powder mixing?
    Kale K; Hapgood K; Stewart P
    Eur J Pharm Biopharm; 2009 May; 72(1):156-64. PubMed ID: 19347972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing.
    de Villiers MM; Van der Watt JG
    Pharm Res; 1994 Nov; 11(11):1557-61. PubMed ID: 7870671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.
    Otsuka M; Kato F; Matsuda Y
    AAPS PharmSciTech; 2002; 3(4):E30. PubMed ID: 12916924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
    Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
    J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel standard sample powder preparation method for quantitative analysis of polymorphs.
    Okumura T; Otsuka M
    J Pharm Sci; 2005 May; 94(5):1013-23. PubMed ID: 15793799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluidized bed film coating of an interactive powder mixture to produce microencapsulated 2-5 microns particles.
    Thiel WJ; Sberna FJ
    J Pharm Pharmacol; 1986 Mar; 38(3):166-71. PubMed ID: 2871149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
    Adi H; Larson I; Stewart PJ
    Int J Pharm; 2007 Jun; 337(1-2):229-38. PubMed ID: 17303354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.